Annie Vereecken is an experienced biotech investor who started as an entrepreneur in gynecological endocrinology and pathology. She built a business in clinical labs acquired by Sonic Healthcare in 2010. Annie actively invests in life sciences companies, including Argenx, Biocartis, MyCartis, Cartagenia (acquired by Agilent Technologies), PharmaFluidics, and Ugentec.